• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对利奈唑胺在成年患者群体药代动力学模型的发表文献进行外部预测性能评估。

External evaluation of the predictive performance of published population pharmacokinetic models of linezolid in adult patients.

机构信息

Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, China.

Department of Pharmacy, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.

出版信息

J Glob Antimicrob Resist. 2023 Dec;35:347-353. doi: 10.1016/j.jgar.2023.08.003. Epub 2023 Sep 4.

DOI:10.1016/j.jgar.2023.08.003
PMID:37573945
Abstract

OBJECTIVES

Several linezolid population pharmacokinetic (popPK) models have been established to facilitate optimal therapy; however, their extrapolated predictive performance to other clinical sites is unknown. This study aimed to externally evaluate the predictive performance of published pharmacokinetic models of linezolid in adult patients.

METHODS

For the evaluation dataset, 150 samples were collected from 70 adult patients (72.9% of which were critically ill) treated with linezolid at our center. Twenty-five published popPK models were identified from PubMed and Embase. Model predictability was evaluated using prediction-based, simulation-based, and Bayesian forecasting-based approaches to assess model predictability.

RESULTS

Prediction-based diagnostics found that the prediction error within ±30% (F) was less than 40% in all models, indicating unsatisfactory predictability. The simulation-based prediction- and variability-corrected visual predictive check and normalized prediction distribution error test indicated large discrepancies between the observations and simulations in most of the models. Bayesian forecasting with one or two prior observations significantly improved the models' predictive performance.

CONCLUSION

The published linezolid popPK models showed insufficient predictive ability. Therefore, their sole use is not recommended, and incorporating therapeutic drug monitoring of linezolid in clinical applications is necessary.

摘要

目的

已建立了多个利奈唑胺群体药代动力学(popPK)模型以促进优化治疗;然而,其对其他临床场所的外推预测性能尚不清楚。本研究旨在对外科成人患者利奈唑胺已发表的药代动力学模型的预测性能进行评估。

方法

在评价数据集方面,从本中心接受利奈唑胺治疗的 70 例成人患者(其中 72.9%为危重症患者)中采集了 150 个样本。从 PubMed 和 Embase 中确定了 25 个已发表的 popPK 模型。采用基于预测、基于模拟和基于贝叶斯预测的方法来评估模型的预测性能,从而评估模型的预测能力。

结果

基于预测的诊断发现,所有模型中预测误差在±30%(F)以内的比例均小于 40%,表明预测能力不理想。基于模拟的预测和变异性校正的可视化预测检查和归一化预测分布误差检验表明,大多数模型的观察值和模拟值之间存在较大差异。使用一个或两个先验观察值进行贝叶斯预测可以显著改善模型的预测性能。

结论

已发表的利奈唑胺 popPK 模型显示出不足的预测能力。因此,不建议单独使用,在临床应用中需要进行利奈唑胺的治疗药物监测。

相似文献

1
External evaluation of the predictive performance of published population pharmacokinetic models of linezolid in adult patients.对利奈唑胺在成年患者群体药代动力学模型的发表文献进行外部预测性能评估。
J Glob Antimicrob Resist. 2023 Dec;35:347-353. doi: 10.1016/j.jgar.2023.08.003. Epub 2023 Sep 4.
2
Systematic external evaluation of published population pharmacokinetic models of mycophenolate mofetil in adult kidney transplant recipients co-administered with tacrolimus.系统评价霉酚酸酯在成人肾移植受者中与他克莫司合用的已发表群体药代动力学模型的外部评估。
Br J Clin Pharmacol. 2019 Apr;85(4):746-761. doi: 10.1111/bcp.13850. Epub 2019 Feb 5.
3
Systematic external evaluation of reported population pharmacokinetic models of vancomycin in Chinese children and adolescents.系统评价中国儿童和青少年万古霉素群体药代动力学模型报告的外部评估。
J Clin Pharm Ther. 2021 Jun;46(3):820-831. doi: 10.1111/jcpt.13363. Epub 2021 Mar 22.
4
Systematic external evaluation of published population pharmacokinetic models for tacrolimus in adult liver transplant recipients.系统评价已发表的成人肝移植受者他克莫司群体药动学模型的外部验证。
Eur J Pharm Sci. 2020 Mar 30;145:105237. doi: 10.1016/j.ejps.2020.105237. Epub 2020 Jan 27.
5
External evaluation of published population pharmacokinetic models of tacrolimus in adult renal transplant recipients.已发表的成人肾移植受者他克莫司群体药代动力学模型的外部评估。
Br J Clin Pharmacol. 2016 May;81(5):891-907. doi: 10.1111/bcp.12830. Epub 2016 Feb 26.
6
External evaluation of population pharmacokinetic models for ciclosporin in adult renal transplant recipients.环孢素在成人肾移植受者群体药代动力学模型的外部评估。
Br J Clin Pharmacol. 2018 Jan;84(1):153-171. doi: 10.1111/bcp.13431. Epub 2017 Nov 3.
7
External evaluation of published population pharmacokinetic models of polymyxin B.多黏菌素 B 群体药代动力学模型发表后评估的外部研究。
Eur J Clin Pharmacol. 2021 Dec;77(12):1909-1917. doi: 10.1007/s00228-021-03193-y. Epub 2021 Aug 3.
8
External evaluation of published population pharmacokinetic models of posaconazole.泊沙康唑已发表群体药代动力学模型的外部评估。
Front Pharmacol. 2022 Sep 30;13:1005348. doi: 10.3389/fphar.2022.1005348. eCollection 2022.
9
Population Pharmacokinetic Evaluation with External Validation of Tacrolimus in Chinese Primary Nephrotic Syndrome Patients.中国原发性肾病综合征患者他克莫司的群体药代动力学评价与外部验证。
Pharm Res. 2022 Aug;39(8):1907-1920. doi: 10.1007/s11095-022-03273-3. Epub 2022 Jun 1.
10
External validation of population pharmacokinetic models of vancomycin in postoperative neurosurgical patients.术后神经外科患者万古霉素群体药动学模型的外部验证。
Eur J Clin Pharmacol. 2023 Aug;79(8):1031-1042. doi: 10.1007/s00228-023-03511-6. Epub 2023 Jun 1.